- Udyam number
- UDYAM-TS-02-0042374

About Alithia Pharmaceuticals Private Limited
Data last updated:
Alithia Pharmaceuticals Private Limited is a private limited company based in Hyderabad, Telangana, India, a subsidiary of Emnar Pharma Private Limited. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 05 July 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24290TG2021PTC152799. Its GSTIN is 36AAVCA4229R1ZS (Telangana). The company holds 2 GST registrations, all of them active.
The company has an authorised share capital of ₹14.4 Lakh and a paid-up capital of ₹14.4 Lakh. It is led by directors including Manikreddy Pullagurla and Mundla Maha Vishnu.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot No 92 1/98/2/92 Kavuri Hills Phase – II Jubilee Hills, Hyderabad, Telangana, India – 500033.
As per the financials filed for FY 2025, the company reported a revenue of ₹12.08 Cr, reflecting significant growth compared to the previous year. For the same year it recorded a net loss of ₹8.94 Cr (net margin -74%) and EBITDA of -₹2.51 Cr (EBITDA margin -20.8%).
The company has about 36 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹27 Cr on record. Court records list 1 case involving the company, including 1 filed by the company.
Alithia Pharmaceuticals Private Limited is registered as an MSME under the Udyam registration framework (Reg. No. UDYAM-TS-02-0042374). For more details, the company can be reached via its website biophore.com.
Company details
Recognitions & Rankings of Alithia Pharmaceuticals
Contact details
Alithia Pharmaceuticals Private Limited's registered office is in Hyderabad, Telangana. Its website is biophore.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressPlot No 92 1/98/2/92 Kavuri Hills Phase – II Jubilee Hills, Hyderabad, Telangana, India – 500033
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Alithia Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Alithia Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Alithia Pharmaceuticals Private Limited, buy the company report.
Financials of Alithia Pharmaceuticals Private Limited
FY 2025 filings availableAlithia Pharmaceuticals Private Limited reported revenue of ₹12.08 Cr (up 292% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue rose 292% in the latest year. EBITDA fell 84% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | -₹2.51 Cr | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | -₹8.94 Cr | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | -20.8% | |||
| Net Profit Margin | -74% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Alithia Pharmaceuticals Private Limited, buy the company report.
Board of directors of Alithia Pharmaceuticals Private Limited
Alithia Pharmaceuticals has 3 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Manikreddy Pullagurla Also directs: Leiutis Pharmaceuticals LLP, Ewings Ventures LLP, Biolyx Lifesciences Private Limited and 5 more | Director | 05 Jul 2021 | 5 Years 4 Months | Current |
| Mundla Maha Vishnu Also directs: Pista Motor Raceway LLP, Ceph Lifesciences Private Limited, Emmennar Pharma Containers Private Limited and 5 more | Director | 05 Jul 2021 | 5 Years 4 Months | Current |
| Jagadeesh Babu Rangisetty Also directs: Leiutis Pharmaceuticals LLP, Ewings Ventures LLP, Envozyme Feeds Private Limited and 5 more | Director | 05 Jul 2021 | 5 Years 4 Months | Current |
Peer comparison
Alithia Pharmaceuticals Private Limited is compared with the 6 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Jayanth Pharmaceuticals Private Limited | ₹12.36 Cr (FY 2025) | -2.0% | Hyderabad, Telangana, India | |||
| Avicura Pharmaceuticals Private Limited | ₹12.32 Cr (FY 2025) | 5.0% | Thane, Maharashtra, India | |||
| Mederal Pharmaceuticals Private Limited | ₹12.25 Cr (FY 2025) | 36.0% | Mumbai, Maharashtra, India | |||
| Tanishka Pharmaceuticals Private Limited | ₹12.13 Cr (FY 2025) | -14.0% | Solan, Himachal Pradesh, India | |||
| Alithia Pharmaceuticals Private Limitedthis company | ₹12.08 Cr (FY 2025) | -₹8.94 Cr | -74% | 292.0% | 36 | Hyderabad, Telangana, India |
| T'walker's Pharmaceuticals Private Limited | ₹12 Cr (FY 2024) | 21.0% | Pune, Maharashtra, India | |||
| Jaju Pharmaceuticals Private Limited | ₹11.82 Cr (FY 2025) | 33.0% | New Delhi, Delhi, India |
To see the full peer comparison of Alithia Pharmaceuticals Private Limited, buy the company report.
Auditor
Alithia Pharmaceuticals Private Limited is audited by VSPN AND CO CHARTERED ACCOUNTANTS for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| VSPN AND CO CHARTERED ACCOUNTANTS | FY 2023 | 008178S |
Shareholding
The shareholding of Alithia Pharmaceuticals Private Limited is on record for 2 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Alithia Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 12 Jul 2022 | 100600079 | Others | ₹27 Cr | Open |
To see the full charge records of Alithia Pharmaceuticals Private Limited, buy the company report.
Total charge records: 1 View all charges
Legal cases
Alithia Pharmaceuticals Private Limited has 1 court case on record: 1 filed by Alithia Pharmaceuticals. All case is disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 1 | 0 | 0 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court, ANDHRAPRADESH | Writ petition | Filed by the company against . Eastern Power Distribution Company of Andhra Pradesh Ltd., and 1 other | Disposed |
To see the full case history of Alithia Pharmaceuticals Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Alithia Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Alithia Pharmaceuticals Private Limited has a workforce of 36 employees on its EPFO records as of May 2026, across 1 active EPFO establishment.
Headcount by financial year
| Financial year | Employees (EPFO) |
|---|---|
| FY 2026-27 | 36 |
| FY 2025-26 | |
| FY 2024-25 | |
| FY 2023-24 |
To see the full employee and EPFO history of Alithia Pharmaceuticals Private Limited, buy the company report.
GST
Alithia Pharmaceuticals has 2 GST registrations: 2 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AAVCA4229R1ZS | Telangana | Active | 02 Nov 2021 |
| 37AAVCA4229R1ZQ | Andhra Pradesh | Active | 08 Jun 2022 |
To see the full GST registrations and return filing status of Alithia Pharmaceuticals Private Limited, buy the company report.
Recent activity
Alithia Pharmaceuticals Private Limited has 3 board changes on record since 2021: 3 appointments. The latest: Jagadeesh Babu Rangisetty was appointed as Director on 05 Jul 2021.
Frequently asked questions
Alithia Pharmaceuticals is an active private limited company based in Hyderabad, Telangana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 05 July 2021 (5+ years old) and is registered under CIN U24290TG2021PTC152799.
Alithia Pharmaceuticals has 3 current directors:
- Manikreddy Pullagurla - Director
- Mundla Maha Vishnu - Director
- Jagadeesh Babu Rangisetty - Director
The latest financial statements of Alithia Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2022 are in the company report.
The GSTIN of Alithia Pharmaceuticals is 36AAVCA4229R1ZS, registered in Telangana. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 37AAVCA4229R1ZQ (Andhra Pradesh).
The CIN (Corporate Identification Number) of Alithia Pharmaceuticals is U24290TG2021PTC152799. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Alithia Pharmaceuticals has 1 court case on record: 1 filed by the company.
Alithia Pharmaceuticals was incorporated on 05 July 2021, making it 5+ years old. It is registered with the Registrar of Companies, Hyderabad.
The peers of Alithia Pharmaceuticals by revenue are Jayanth Pharmaceuticals Private Limited, Avicura Pharmaceuticals Private Limited, Mederal Pharmaceuticals Private Limited, Tanishka Pharmaceuticals Private Limited, T'walker's Pharmaceuticals Private Limited and 1 more, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Jagadeesh Babu Rangisetty was appointed as Director on 05 Jul 2021. Manikreddy Pullagurla was appointed as Director on 05 Jul 2021. Mundla Maha Vishnu was appointed as Director on 05 Jul 2021.
Yes, Alithia Pharmaceuticals is registered as an MSME under Udyam registration (number: UDYAM-TS-02-0042374).
Alithia Pharmaceuticals can be reached through the website biophore.com. Its registered office is in Hyderabad, Telangana, India.

